CSL-360

• Target:

  Interleukin

• Related Pathways:

  Immunology/Inflammation

• Bioactivity:

  CSL-360 is a chimeric non-conjugated IgG1 monoclonal antibody that targets CD123. It effectively inhibits the binding of IL-3 to CD123, thereby preventing IL-3-induced cell proliferation. CSL-360 is utilized in research related to acute myeloid leukemia (AML) .

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C